The DD genotype of the ace gene polymorphism is associated with diabetic nephropathy in type-1 diabetics

Endocrine Research

Volumn 27, Issue 1-2, 2001, Pages 99-108

  Azar, S T ^a   Zalloua, P A ^a   Medlej, R ^a   Halabi, G ^a  

^a Chronic Center for Diabetes   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DNA;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PRIORITY JOURNAL;

ADULT; ALBUMINURIA; ALLELES; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC;

EID: 0034978822     PISSN: 07435800     EISSN: None     Source Type: Journal    
DOI: 10.1081/ERC-100107173     Document Type: Article

References (42)

1. Diabetic nephropathy in type-1(insulin dependent) diabetes: An epidemiological study
2. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin dependent diabetes mellitus
3. The effect of intensive treatment of diabetes on the development progression of long term complications in insulin dependent diabetes mellitus
4. Risk factors for development of microalbuminuria in insulin dependent diabetic patients: A cohort study
5. Effect of captopril on progression to clinical proteinuria in patients with insulin dependent diabetes and microalbuminuria
6. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy
7. Is diabetic nephropathy an inherited complication?
8. Relationship between angiotensin I converting enzyme gene polymorphism plasma levels, and diabetic retinal and renal complications
9. Lack of a relationship between an insertion/deletion polymorphism of angiotensin I converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients
10. Meta-analysis of association of insertion/deletion polymorphism of angiotensin I converting enzyme gene with diabetic nephropathy and proliferative retinopathy
11. An insertion/deletion polymorphism in the angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels
12. Polymorphism of the angiotensin-converting enzyme gene and cardiovascular diseases
13. Angiotensin I converting enzyme gene: Regulation polymorphism and implications in cardiovascular diseases
14. Polymorphisms of the angiotensin I converting enzyme gene in subjects who die from coronary heart disease
15. Angiotensin converting enzyme DD genotype and cardiovascular disease in heterozygous familial hypercholesterolemia
16. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham heart study
17. Genetic associations with human longevity at the APOE and ACE loci
18. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
19. Deletion polymorphism in angiotensin I converting enzyme gene associated with parental history of myocardila infarction
20. Insertion/deletion polymorphism in angiotensin I converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy
21. A prospective evaluation of an angiotensin I converting enzyme gene polymorphism and the risk of ischemic heart disease
22. Insertion/deletion polymorphism of the angiotensin I converting enzyme gene is strongly associated with coronary heart disease in non-insulin dependent diabetes mellitus
23. Genetics of diabetic nephropathy
24. Diabetic nephropathy and the insertion/deletion polymorphism of the angiotensin I converting enzyme gene
25. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP 1) (Dipeptyl Carboxypeptidase 1)
26. Deletion polymorphism of the angiotensin converting enzyme gene in patients with a history of ischemic stroke
27. Prevalence of the causes of albuminuria in non-insulin-dependent diabetic patients
28. Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus
29. Excess of DD hemozygotes in ȟemodialysed patients with type II diabetes
30. Angiotensin I converting enzyme gene polymorphism and diabetic nephropathy in type II diabetes
31. Effect of deletion polymorphism of angiotensin converting enzyme gene of progression of diabetic nephropathy during inhibition of angiotensin converting enzyme gene: Observational follow-up study
32. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes
33. Deletion insertion polymorphism of the angiotensin converting enzyme gene and progression of diabetic nephropathy
34. Metabolic and gene predictor of progression of diabetic kidney disease
35. Progression of diabetic nephropathy during long standing angiotensin converting enzyme (ACE) inhibition-the impact polymorphisms in the renin-angiotensin system
36. Polymorphism in angiotensin converting enzyme gene and progression of IgA nephropathy
37. Association between angiotensin converting enzyme gene polymorphism and failure of renoprotective therapy
38. Glomerular structure in type-1 (Insulin Dependent) diabetic patients with normo and microalbuminuria
39. Examination of two genetic polymorphisms within the renin-angiotensin system: No evidence for an association with nephropathy in IDDM
40. Association of ACE gene polymorphism and diabetic nephropathy?
41. Genetic variation of renin-angiotensin system, diabetic nephropathy and hypertension